Predictors for Pouchitis After Ileal Pouch-Anal Anastomosis for Pediatric-Onset Ulcerative Colitis

Yuhki Koike1, Keiichi Uchida1, Mikihiro Inoue1

  • 1Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

Insights

High cumulative steroid doses and elevated neutrophil percentages before surgery predict pouchitis in pediatric ulcerative colitis patients undergoing IPAA. These factors are crucial for identifying at-risk individuals.

Area of Science:

  • Gastroenterology
  • Pediatric Surgery
  • Inflammatory Bowel Disease Research

Background:

  • Pouchitis is a common complication following ileal pouch-anal anastomosis (IPAA) in pediatric ulcerative colitis (UC).
  • Predictive factors for pouchitis in this specific population remain underexplored, necessitating further investigation.

Purpose of the Study:

  • To identify preoperative and intraoperative predictors of pouchitis development after IPAA in pediatric UC patients.
  • To establish a basis for risk stratification and potential preventative strategies.

Main Methods:

  • Retrospective analysis of 54 pediatric UC patients who underwent IPAA between 2000 and 2017.
  • Statistical analysis including Cox regression, t-tests, Mann-Whitney U tests, and Kaplan-Meier curves to identify predictors.
  • Pouchitis defined as a modified pouchitis disease activity index score of ≥5.

Main Results:

  • Pouchitis developed in 31.5% of patients within 5 years of follow-up.
  • Independent predictors for pouchitis included a cumulative steroid dose >10,000 mg and a neutrophil percentage >65% before IPAA.
  • Patients with neither predictor had no pouchitis, while over 40% with one or both predictors developed pouchitis.

Conclusions:

  • Elevated cumulative steroid dose and high preoperative neutrophil percentage are significant predictors of pouchitis in pediatric UC patients.
  • These findings can aid in identifying high-risk patients for pouchitis post-IPAA.
Abstract

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
508
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
978
Psychosexual Stages of Personality: Anal01:26

Psychosexual Stages of Personality: Anal

Sigmund Freud's theory of psychosexual development describes the anal stage as occurring between 18 months and three years of age. During this period, children derive pleasure from controlling and releasing their bowel movements. However, they quickly learn that societal expectations impose restrictions on when and where this can happen. This stage marks a critical point where children begin to develop a sense of control and mastery over their bodily functions, as well as their broader...
3.9K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.0K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
808
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259